Lin W W, Chen B C
Department of Pharmacology, College of Medicine, National Taiwan University, Taipei.
Br J Pharmacol. 1998 Dec;125(7):1601-9. doi: 10.1038/sj.bjp.0702219.
The modulatory effects of protein kinase C (PKC) on the activation of cytosolic phospholipase A2 (cPLA2) and adenylyl cyclase (AC) have recently been described. Since the signalling cascades associated with these events play critical roles in various functions of macrophages, we set out to investigate the crosstalk between PKC and the cPLA2 and AC pathways in mouse RAW 264.7 macrophages and to determine the involvement of individual PKC isoforms. The cPLA2 and AC pathways were studied by measuring the potentiation by the phorbol ester PMA of ionomycin-induced arachidonic acid (AA) release and prostagladin E1 (PGE1)-stimulated cyclic AMP production, respectively. PMA at 1 microM caused a significant increase in AA release both in the presence (371%) and absence (67%) of ionomycin induction, while exposure of RAW 264.7 cells to PMA increased PGE1 stimulation of cyclic AMP levels by 208%. Treatment of cells with staurosporine and Ro 31-8220 inhibited the PMA-induced potentiation of both AA release and cyclic AMP accumulation, while Go 6976 (an inhibitor of classical PKC isoforms) and LY 379196 (a specific inhibitor of PKCbeta) inhibited the AA response but failed to affect the enhancement of the cyclic AMP response by PMA. Long term pretreatment of cells with PMA abolished the subsequent effect of PMA in potentiating AA release, but only inhibited the cyclic AMP response by 42%. Neither PD 98059, an inhibitor of MEK, nor genistein, an inhibitor of tyrosine kinases, had any effect on the ability of PMA to potentiate AA or cyclic AMP production. The potentiation of AA release, but not of cyclic AMP formation, by PMA was sensitive to inhibition by wortmannin. This effect was unrelated to the inhibition of PKC activation as deduced from the translocation of PKC activity to the cell membrane. Western blot analysis revealed the presence of eight PKC isoforms (alpha, betaI, betaII, delta, epsilon, mu, lambda and xi) in RAW 264.7 cells and PMA was shown to induce the translocation of the alpha, betaI, betaII, delta, epsilon and mu isoforms from the cytosol to the cell membrane within 2 min. Pretreatment of cells with PMA for 2-24 h resulted in a time-dependent down-regulation of PKCalpha, betaI, betaII, and delta expression, while the levels of the other four PKC isozymes were unchanged after PMA treatment for 24 h. A decrease in the potentiation of AA release by PMA was observed, concomitant with the time-dependent down-regulation of PKC. These results indicate that PKCbeta has a crucial role in the mediation of cPLA2 activation by the phorbol ester PMA, whereas PMA utilizes PKC epsilon and/or mu to up-regulate AC activity.
最近已有关于蛋白激酶C(PKC)对胞质型磷脂酶A2(cPLA2)和腺苷酸环化酶(AC)激活的调节作用的描述。由于与这些事件相关的信号级联在巨噬细胞的各种功能中起着关键作用,我们着手研究小鼠RAW 264.7巨噬细胞中PKC与cPLA2和AC途径之间的相互作用,并确定各个PKC亚型的参与情况。分别通过测量佛波酯PMA对离子霉素诱导的花生四烯酸(AA)释放的增强作用以及前列腺素E1(PGE1)刺激的环磷酸腺苷(cAMP)生成,来研究cPLA2和AC途径。1μM的PMA在离子霉素诱导存在(371%)和不存在(67%)的情况下均导致AA释放显著增加,而RAW 264.7细胞暴露于PMA使PGE1对cAMP水平的刺激增加了208%。用星形孢菌素和Ro 31 - 8220处理细胞可抑制PMA诱导的AA释放和cAMP积累的增强,而Go 6976(经典PKC亚型的抑制剂)和LY 379196(PKCβ的特异性抑制剂)抑制AA反应,但未能影响PMA对cAMP反应的增强。用PMA对细胞进行长期预处理消除了PMA随后增强AA释放的作用,但仅将cAMP反应抑制了42%。MEK抑制剂PD 98059和酪氨酸激酶抑制剂染料木黄酮均对PMA增强AA或cAMP生成的能力没有任何影响。PMA对AA释放的增强作用(而非对cAMP形成的增强作用)对渥曼青霉素的抑制敏感。从PKC活性向细胞膜的转位推断,这种作用与PKC激活的抑制无关。蛋白质印迹分析显示RAW 264.7细胞中存在八种PKC亚型(α、βI、βII、δ、ε、μ、λ和ξ),并且显示PMA可在2分钟内诱导α、βI、βII、δ、ε和μ亚型从胞质溶胶转位至细胞膜。用PMA对细胞进行2 - 24小时的预处理导致PKCα、βI、βII和δ表达随时间依赖性下调,而在PMA处理24小时后,其他四种PKC同工酶的水平未发生变化。观察到PMA对AA释放的增强作用降低,同时伴随着PKC的时间依赖性下调。这些结果表明,PKCβ在佛波酯PMA介导的cPLA2激活中起关键作用,而PMA利用PKCε和/或μ来上调AC活性。